JW Pharmaceutical Corporation (KRX:001060)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,150
+150 (0.65%)
Feb 21, 2025, 9:00 AM KST

JW Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
73,41037,00631,892-967.85-15,241-25,275
Upgrade
Depreciation & Amortization
19,38222,57516,83616,11220,68820,349
Upgrade
Loss (Gain) From Sale of Assets
21.811,088-3.281,04812.24-18.15
Upgrade
Asset Writedown & Restructuring Costs
--4,821--85
Upgrade
Loss (Gain) From Sale of Investments
-2,966-2,8308,5151,820--
Upgrade
Loss (Gain) on Equity Investments
-1,723-621.061,3491,1491,924369.17
Upgrade
Provision & Write-off of Bad Debts
-6,029-3,6448,43712,0736,8707,336
Upgrade
Other Operating Activities
26,35253,846-8,91332,94613,584-10,227
Upgrade
Change in Accounts Receivable
28,893-4,734-4,312-41,56645,20837,302
Upgrade
Change in Inventory
-8,6608,917-11,541-2,655-8,87619,784
Upgrade
Change in Accounts Payable
-13,997-9,53631,6523,7302,831-632.93
Upgrade
Change in Unearned Revenue
-0-153.66-53.5--199.22-796.89
Upgrade
Change in Other Net Operating Assets
-19,608-14,756-21,915-5,564-3,7477,256
Upgrade
Operating Cash Flow
95,07687,15756,76418,12463,05455,531
Upgrade
Operating Cash Flow Growth
25.02%53.54%213.20%-71.26%13.55%6.57%
Upgrade
Capital Expenditures
-8,715-27,286-9,919-7,467-12,387-9,285
Upgrade
Sale of Property, Plant & Equipment
30.6624.976.2663,44665.5862.71
Upgrade
Cash Acquisitions
-164.96-12,005-40.88---4,224
Upgrade
Divestitures
---384.96--
Upgrade
Sale (Purchase) of Intangibles
-20,657-13,419-2,433-5,435-2,652-3,892
Upgrade
Investment in Securities
20,8938,260-26,3441,078-61,955-1,125
Upgrade
Other Investing Activities
2,349-6,355267.37-44,541501.19-49.68
Upgrade
Investing Cash Flow
35.7-63,780-18,919-22,869-79,427-21,984
Upgrade
Short-Term Debt Issued
-227,876110,89675,32394,683148,575
Upgrade
Long-Term Debt Issued
-60,16629,58560,29670,00020,000
Upgrade
Total Debt Issued
166,617288,042140,481135,619164,683168,575
Upgrade
Short-Term Debt Repaid
--316,108-177,004-84,408-142,087-142,875
Upgrade
Long-Term Debt Repaid
--4,051-2,795-16,845-29,427-17,810
Upgrade
Total Debt Repaid
-246,137-320,159-179,799-101,254-171,515-160,685
Upgrade
Net Debt Issued (Repaid)
-79,520-32,117-39,31834,365-6,8317,891
Upgrade
Issuance of Common Stock
--10,000398.47--
Upgrade
Repurchase of Common Stock
-332.45-260.88-281.6-412.29-224.25-258.46
Upgrade
Common Dividends Paid
-9,665-8,814-7,352-7,149-6,954-6,816
Upgrade
Other Financing Activities
-0-5444-0--24,977
Upgrade
Financing Cash Flow
-89,518-41,245-36,90727,202-14,009-24,160
Upgrade
Foreign Exchange Rate Adjustments
60.21-120.69-406.38458.72-1,0311,529
Upgrade
Miscellaneous Cash Flow Adjustments
00----
Upgrade
Net Cash Flow
5,654-17,989531.4522,915-31,41310,916
Upgrade
Free Cash Flow
86,36159,87146,84510,65750,66746,246
Upgrade
Free Cash Flow Growth
70.21%27.81%339.56%-78.97%9.56%6.38%
Upgrade
Free Cash Flow Margin
11.73%8.00%6.85%1.76%9.26%9.04%
Upgrade
Free Cash Flow Per Share
1506.562565.562016.97459.202182.011992.45
Upgrade
Cash Interest Paid
8,91011,1199,0357,5677,64010,970
Upgrade
Cash Income Tax Paid
13,31113,33531,621863.42-1,4175,463
Upgrade
Levered Free Cash Flow
46,78823,38174,265-6,67254,56559,773
Upgrade
Unlevered Free Cash Flow
53,33231,23280,132-2,08759,30766,822
Upgrade
Change in Net Working Capital
-2,44911,032-37,84224,577-54,485-71,534
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.